Top Republican calls for 340B reform in long-awaited investigation

Top Republican calls for 340B reform in long-awaited investigation

Sen. Bill Cassidy’s report calls on Congress to improve program transparency, like requiring covered entities to show how they use 340B funds. Drug groups praised the findings, while hospitals argued the analysis was limited in scope.

340B changes loom as the program attracts congressional, White House scrutiny

Both Congress and the White House are proposing 340B Drug Pricing Program changes that could add administrative burdens and ultimately limit the available savings for hospitals. A new report issued by Republican members of the Senate Health, Education, Labor and Pensions (HELP) Committee calls for changes that include requiring 340B covered entities to “provide detailed annual reporting on how 340B revenue is used to ensure direct savings for pa…

Cassidy releases report calling for reforms to 340B program

Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation into how covered entities use and generate revenue from the 340B Drug Pricing Program. As part of his investigation, Cassidy requested information from hospitals, Federally Qualified Health Centers, contract pharmacies and drug manufacturers.  Cassidy said the “investigation underscores that…

Senate HELP Committee Chair Cassidy Calls for Federal 340B Reforms, Releases Findings of Yearslong Congressional Probe - 340B Report

The leader of a key U.S. Senate Committee tasked with overseeing the 340B program called Thursday for Congress to improve [...] The post Senate HELP Committee Chair Cassidy Calls for Federal 340B Reforms, Releases Findings of Yearslong Congressional Probe appeared first on 340B Report.